在治疗无并发性胆结石病的共享决策:一个横截面试点研究
Martin Alavi Treider1, Simone Kienlin2, Thomas J Fyhn3
1Department for Gastrointestinal Surgery Oslo University Hospital Mailbox 4950 Nydalen Oslo 0424 Norway Faculty of Medicine University of Oslo Oslo Norway.
概括
在胆结石疾病治疗中,共享决策 (SDM) 显示了适度的患者参与,尽管人们的看法各不相同. 较高的SDM分数与选择手术相关,表明需要改善护理的一致性.
科学领域:
- 医疗决策的制定 医疗决策的制定
- 手术患者护理手术患者护理
- 医疗保健服务研究 医疗服务研究
背景情况:
- 共享决策 (SDM) 对于无并发性胆结石疾病的治疗选择至关重要,在这种情况下,手术和保守的选择都是可行的.
- 鉴于可用的选择的安全性,患者的偏好是治疗决策的核心.
研究的目的:
- 评估患者参与无并发性胆结石病治疗的共同决策的程度.
- 为了比较患者,外科医生和外部观察者对SDM的看法.
主要方法:
- 在挪威外科门诊进行前性试点研究.
- 对视频录制的咨询和来自患者,外科医生和专家评价人的MAPPIN-SDM问卷数据的分析.
- 根据11项 (0-4) 计算的MAPPIN-SDM分数,较高的分数表明更大的SDM.
主要成果:
- 包括26名患有无并发性胆结石疾病的患者;68%是女性,平均年龄为47.8岁.
- 总体平均MAPPIN-SDM得分为2.6;患者 (3.5) 和外科医生 (2.9) 报告的SDM高于观察者 (1.55;p < 0.001).
- 接受手术的患者 (54%) 的SDM得分 (2.89) 比保守管理的患者 (2.28;p < 0.001) 高得多.
结论:
- 在不复杂的胆结石疾病咨询中存在中等水平的SDM.
- 在患者/外科医生的看法和观察者对SDM的评估之间发现了显著的差异.
- 更高的SDM与手术治疗选择有关,强调需要策略来提高SDM质量和一致性.
相关概念视频
Cross-Sectional Research
12.7K
In cross-sectional research, a researcher compares multiple segments of the population at the same time. If they were interested in people's dietary habits, the researcher might directly compare different groups of people by age. Instead of following a group of people for 20 years to see how their dietary habits changed from decade to decade, the researcher would study a group of 20-year-old individuals and compare them to a group of 30-year-old individuals and a group of 40-year-old...
12.7K
Finding Volume Using Cross-Sectional Area
99
For solids whose cross-sectional areas vary in a predictable way, volume can be determined by integrating these areas along an axis perpendicular to the slices. This approach is particularly useful for polyhedral solids, where classical geometric formulas may not be immediately applicable. A tetrahedron provides a clear example of how cross-sectional integration can be applied to a three-dimensional object with continuously changing geometry.Consider a tetrahedron with height h and a base that...
99
Profile Leveling and Cross Sections
1.7K
Profile leveling and cross-sections are surveying methods used to determine and document terrain elevations for infrastructure projects such as highways, railroads, canals, and pipelines. These methods provide data for earthwork planning and alignment of proposed routes. Profile leveling involves measuring elevations along a fixed line to create a vertical terrain profile. A surveyor sets up a leveling instrument at the benchmark (BM) and records a backsight (BS) to determine the...
1.7K
Spinal Cord: Cross-sectional Anatomy
5.0K
The cross-sectional anatomy of the spinal cord offers a detailed view of its complex structure and function within the central nervous system. At the core of the spinal cord lies the gray matter, characterized by its butterfly or "H"-shaped appearance in cross-section. This central region is enveloped by white matter, with the overall structure divided into symmetrical halves by the dorsal median sulcus and the ventral median fissure.
Gray Matter and its Components
Central to the gray matter is...
Gray Matter and its Components
Central to the gray matter is...
5.0K
Parkinson's Disease: Treatment
1.2K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
Alzheimer's Disease: Treatment
981
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
981


